Publication | Closed Access
A Synthetic Vaccine Consisting of a Tumor‐Associated Sialyl‐T<sub>N</sub>‐MUC1 Tandem‐Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response
145
Citations
32
References
2009
Year
Vaccine AImmunologyImmunoeditingCd4 T Cell ResponsesImmunotherapeuticsImmunotherapySynthetic ImmunologyTumor ImmunologyTetanus ToxoidTumor ImmunityMucosal VaccinationAllergyTherapeutic VaccineSynthetic Vaccine ConsistingT Cell ImmunityVaccinationIdeal CombinationVaccine DesignMolecular WeightMedicine
An ideal combination: The vaccine A is obtained by conjugation of the synthetic tumor-associated sialyl-TN-MUC1 glycopeptide antigen to tetanus toxoid (molecular weight >150 000). Vaccine A induces a very strong and selective immune response against the glycopeptide structure in wild-type mice (Balb/c).
| Year | Citations | |
|---|---|---|
Page 1
Page 1